Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy

Thomas Czech1, Jae-Won Yang, Edina Csaszar

  • 1Department of Neurosurgery, University of Vienna, Waehringer Guertel 18, A-1090 Vienna, Austria.

Neurochemical Research
|January 28, 2005
PubMed

Insights

Mesial temporal lobe epilepsy (MTLE) involves altered collapsin response mediated protein-2 (CRMP-2) in the hippocampus. Reduced CRMP-2 may underlie neurodegeneration and impaired brain wiring in MTLE patients.

Area of Science:

  • Neuroscience
  • Proteomics
  • Epilepsy Research

Background:

  • Mesial temporal lobe epilepsy (MTLE) pathogenesis remains unclear despite recent advances.
  • Hippocampal sclerosis is a common hallmark of MTLE, suggesting crucial roles for hippocampal dysfunction.

Purpose of the Study:

  • To investigate protein alterations in the hippocampus of MTLE patients.
  • To identify specific proteins involved in MTLE pathomechanisms.

Main Methods:

  • Proteomic analysis using two-dimensional gel electrophoresis and MALDI-MS on hippocampal tissue from MTLE patients and controls.
  • Immunoblotting to confirm protein expression levels.

Main Results:

  • Derangement of collapsin response mediated protein-2 (CRMP-2) was detected in MTLE hippocampi.
  • A significant decrease in 55 kDa CRMP-2 spots and altered 65 kDa CRMP-2 spots were observed in MTLE.
  • Immunoblotting confirmed extremely low expression of the 55 kDa CRMP-2 band in MTLE.

Conclusions:

  • Reduced CRMP-2 levels in MTLE may indicate impaired neuronal plasticity, neurodegeneration, and abnormal brain wiring.
  • CRMP-2 deficiency could contribute to the pathomechanisms underlying MTLE and abnormal neuronal migration.

Related Concept Videos